Vaccine & Viral Therapies
Animal-origin-free components for viral vaccine and oncolytic virus production.
From viral propagation and upstream processing to purification and final formulation, InVitria’s animal-origin-free recombinant proteins and cell culture solutions support viral vaccine and oncolytic virus development. Explore solutions designed to support viral productivity, process consistency, and product stability.
Explore Our Viral Vaccine & Oncolytic Virus Applications
Each routes to a workflow page showing exactly where InVitria proteins fit.
Defined Solutions for Viral Production, Processing & Formulation
Viral vaccine and oncolytic virus manufacturing require consistent raw materials to support cell growth, viral production, purification, and final product stability.
Traditional serum-containing and hydrolysate-based processes can introduce raw material variability and additional qualification requirements. Animal-origin-free recombinant proteins and chemically defined media offer alternatives for developing more controlled manufacturing processes.
InVitria’s portfolio includes recombinant human albumin, recombinant transferrin, and cell culture media solutions for evaluation across upstream and downstream workflows. These products can support the development of scalable manufacturing processes while reducing reliance on animal-derived and plasma-derived raw materials.
Talk to the ProApps team
Discuss your vaccine or viral therapy program.
The step you are solving for, the format and grade, the inclusion level, the scale, and the regulatory file the program has to support.